Frequently Asked Questions

It is a pioneering genomic Newborn Screening Research Program, that includes all newborns in Bahrain. A small blood sample is taken from the umbilical cord and stored in the biobank using specialized methods, with the aim of conducting whole genomic sequencing in the gradual phases of the program. This program aims to achieve several sustainable goals, including:

1. Early detection of genetic diseases and the development of a comprehensive national health outlook for future generations.
2. Enhancing treatment opportunities and early interventions to reduce mortality rates and long-term complications.
3. Supporting genetic research and advancing personalized medicine and its applications in Bahrain and the region.
4. Assessing the healthcare costs of genetic diseases and formulating comprehensive policies for proactive healthcare.

• Bahraini Genome Program –Research (For adults over 18 years old, and with parental consent for minors).
• (gNBS-RP) Genetic Newborn Screening– Research Program (For newborns in governmental and private hospitals).
• Additional programs and services to be introduced in the near future.